7Baggers
 concentra picks up cargo in latest troubled biotech buyout  insights.citeline.com Tue, 08 Jul 2025 20:28:52 GMT
 concentra buys out another struggling boston biotech  The Business Journals Mon, 09 Jun 2025 07:00:00 GMT
 press release distribution & pr platform  ACCESS Newswire Sun, 27 Apr 2025 01:55:43 GMT
 Tang Capital’s Concentra nabs a win, making a deal to buy Allakos  Endpoints News Wed, 02 Apr 2025 07:00:00 GMT
 climb bio appoints seasoned biotech leaders to board of directors  The Manila Times Tue, 01 Apr 2025 11:19:41 GMT
 jounce therapeutics, inc. to host earnings call  ACCESS Newswire Mon, 10 Mar 2025 02:05:56 GMT
 jounce therapeutics, inc. to host earnings call  ACCESS Newswire Fri, 07 Mar 2025 11:16:44 GMT
 Biotech Companies Redx Pharma, Jounce Therapeutics To Merge In USD 425 Mn Deal  BW Healthcare World Wed, 12 Feb 2025 00:57:14 GMT
 kezar rejects concentra bid that 'substantially undervalues' the biotech  Fierce Biotech Thu, 17 Oct 2024 07:00:00 GMT
 lucy therapeutics appoints kim drapkin as board chair  Business Wire Tue, 15 Oct 2024 07:00:00 GMT
 jounce therapeutics  The Pharma Letter Tue, 02 Jul 2024 18:36:13 GMT
 jounce therapeutics  The Pharma Letter Sat, 29 Jun 2024 04:09:44 GMT
 jounce therapeutics | biotechnology | the pharmaletter  The Pharma Letter Sat, 29 Jun 2024 04:09:44 GMT
 we're a little worried about jounce therapeutics' (nasdaq:jnce) cash burn rate  Yahoo New Zealand News Fri, 28 Jun 2024 00:53:21 GMT
 jounce therapeutics, inc. (jnce) reports q4 loss, lags revenue estimates  Yahoo Canada Shine On Sat, 22 Jun 2024 10:43:11 GMT
 top ranked value stocks to buy for october 29th  Yahoo Lifestyle UK Mon, 27 May 2024 02:52:41 GMT
 jounce (jnce) select study fails to meet goal, stock down  Yahoo New Zealand News Mon, 20 May 2024 23:48:45 GMT
 jounce (jnce) select study fails to meet goal, stock down  Yahoo New Zealand News Thu, 16 May 2024 17:28:23 GMT
 jounce therapeutics, inc. (jnce) reports q2 loss, tops revenue estimates  Yahoo Movies Canada Sun, 12 May 2024 20:14:18 GMT
 ers international congress 2016 - concentra biosciences  The Pharma Letter Mon, 06 May 2024 12:20:54 GMT
 jounce (jnce) up 41% on buyout offer from concentra biosciences  Yahoo Movies Canada Sat, 04 May 2024 07:00:00 GMT
 jounce therapeutics, inc. (jnce) reports q2 loss, tops revenue estimates  Yahoo Movies Canada Tue, 30 Apr 2024 21:17:17 GMT
 theseus investor seeks appraisal after concentra merger  Law360 Tue, 02 Apr 2024 07:00:00 GMT
 jounce dumps redx pharma for acquisition by concentra; to cut 84% of jobs  Yahoo Sport Australia Wed, 27 Mar 2024 07:00:00 GMT
 is jounce therapeutics (jnce) stock outpacing its medical peers this year?  Yahoo Movies Canada Tue, 26 Mar 2024 03:43:05 GMT
 bounce for jounce on competing takeover bid from concentra  FirstWord Pharma Tue, 09 Jan 2024 22:47:06 GMT
 The definitive Boston biotech layoff tracker for 2023  The Business Journals Tue, 02 Jan 2024 08:00:00 GMT
 concentra scores another win as theseus agrees to buyout offer  Fierce Biotech Fri, 22 Dec 2023 08:00:00 GMT
 tang capital’s concentra offers $465m cash buyout of lianbio  BioWorld Online Tue, 05 Dec 2023 08:00:00 GMT
 tang capital's concentra offers $465m cash buyout of lianbio  BioWorld Online Tue, 05 Dec 2023 08:00:00 GMT
 roche paying $2.7b up front for obesity player carmot  BioWorld Online Mon, 04 Dec 2023 16:00:00 GMT
 Tang Capital’s Concentra offers $465M cash buyout of Lianbio  BioWorld MedTech Mon, 04 Dec 2023 08:00:00 GMT
 tang capital's concentra offers $465m cash buyout of lianbio  BioWorld Online Mon, 04 Dec 2023 08:00:00 GMT
 lianbio confirms unsolicited bid from concentra biosciences  The Pharma Letter Sat, 02 Dec 2023 08:00:00 GMT
 endpoints news — arch-affiliated vc raises $200m to fund ...  Endpoints News Fri, 01 Dec 2023 22:23:11 GMT
 concentra back with another buyout offer, this time for lianbio  FierceBiotech Fri, 01 Dec 2023 16:03:00 GMT
 after targeting struggling biotechs, tang's concentra shifts gears ...  Endpoints News Fri, 01 Dec 2023 12:08:00 GMT
 concentra makes fifth takeover approach of the year, this time to lianbio  FirstWord Pharma Fri, 01 Dec 2023 08:00:00 GMT
 concentra, on the hunt for deals, bids for lianbio  BioPharma Dive Fri, 01 Dec 2023 08:00:00 GMT
 phenomic signs $509m deal with boehringer for cancer targets  BioWorld Online Wed, 29 Nov 2023 22:24:15 GMT
 san diego vc, orbimed make competing buyout offers for struggling theseus  The Business Journals Mon, 27 Nov 2023 08:00:00 GMT
 troubled theseus mulls bids from both orbimed and concentra  Fierce Biotech Mon, 27 Nov 2023 08:00:00 GMT
 cheshire biotech firm's £14m share issue approved ...  The Business Desk Mon, 06 Nov 2023 08:00:00 GMT
 redx pharma raises £14m to support 'strong progress' of its drug portfolio  The Business Desk Wed, 18 Oct 2023 07:00:00 GMT
 concentra makes bid for struggling biotech rain  BioPharma Dive Mon, 16 Oct 2023 07:00:00 GMT
 concentra offers to buy troubled rain oncology  Fierce Biotech Mon, 16 Oct 2023 07:00:00 GMT
 systemic therapy for small-cell lung cancer: asco-ontario health ...  ASCO Journals Wed, 11 Oct 2023 07:00:00 GMT
 biotech layoffs 2023: massachusetts hit hard after years of hype  The Boston Globe Tue, 10 Oct 2023 07:00:00 GMT
 building a new arsenal of therapeutics from oncolytic viruses  BioPharm International Tue, 10 Oct 2023 07:00:00 GMT
 mypathway human epidermal growth factor receptor 2 basket ...  ASCO Journals Wed, 04 Oct 2023 07:00:00 GMT
 harnessing the power of oncolytic viruses  BioPharm International Wed, 20 Sep 2023 07:00:00 GMT
 bempegaldesleukin plus nivolumab in untreated advanced ...  ASCO Journals Thu, 31 Aug 2023 07:00:00 GMT
 board member resigns from biotech firm redx  BusinessCloud Wed, 23 Aug 2023 07:00:00 GMT
 systemic therapy for melanoma: asco guideline update | journal ...  ASCO Journals Mon, 14 Aug 2023 07:00:00 GMT
 impact of bmi in patients with early hormone receptor–positive ...  ASCO Journals Wed, 09 Aug 2023 07:00:00 GMT
 robert kamen net worth (2025)  GuruFocus Thu, 27 Jul 2023 12:44:41 GMT
 enfortumab vedotin continues to show promise as neoadjuvant ...  Urology Times Tue, 25 Jul 2023 07:00:00 GMT
 stanford president resigns—chutes & ladders  FierceBiotech Fri, 21 Jul 2023 07:00:00 GMT
 prospective correlation of magnetic resonance tumor regression ...  ASCO Journals Fri, 21 Jul 2023 07:00:00 GMT
 chutes & ladders—flagship plucks former bms r&d exec rupert ...  FierceBiotech Fri, 14 Jul 2023 07:00:00 GMT
 crossbow therapeutics launches with $80 million in series a ...  BioSpace Tue, 11 Jul 2023 07:00:00 GMT
 pfizer, lilly back startup headed by former astrazeneca chief ...  The Business Journals Tue, 11 Jul 2023 07:00:00 GMT
 acquisitions drive growth in pharma and biotech in the first half of 2023  The Pharma Letter Mon, 03 Jul 2023 07:00:00 GMT
 enfortumab vedotin with or without pembrolizumab in cisplatin ...  ASCO Journals Tue, 27 Jun 2023 07:00:00 GMT
 cyclin-dependent kinase inhibitor clinical trial pipeline ...  GlobeNewswire Wed, 21 Jun 2023 07:00:00 GMT
 intracranial efficacy of adagrasib in patients from the krystal-1 ...  ASCO Journals Fri, 16 Jun 2023 07:00:00 GMT
 first-in-human, phase i dose-escalation and dose-expansion ...  ASCO Journals Fri, 16 Jun 2023 07:00:00 GMT
 biotech growth trails benchmark by miles  QuotedData Thu, 15 Jun 2023 07:00:00 GMT
 reconnecting with patients to 'rediscover joy of oncology'  Medscape Mon, 05 Jun 2023 07:00:00 GMT
 many biotechs are worth more dead than alive  Barron's Mon, 05 Jun 2023 07:00:00 GMT
 patient-reported outcomes during and after treatment for locally ...  ASCO Journals Sun, 04 Jun 2023 07:00:00 GMT
 ryan sansom  Cooley Thu, 01 Jun 2023 08:23:53 GMT
 San Diego VC tries to buy out a second Boston biotech  The Business Journals Wed, 31 May 2023 07:00:00 GMT
 infinity's merger with mei in doubt after investors make their own bid  Fierce Biotech Wed, 31 May 2023 07:00:00 GMT
 infinity merger with mei in doubt after surprise buyer makes bid  Fierce Biotech Wed, 31 May 2023 07:00:00 GMT
 Atea rejects takeover bid from Concentra  BioPharma Dive Tue, 30 May 2023 07:00:00 GMT
 atea rejects 'undervalued' offer from concentra  Fierce Biotech Tue, 30 May 2023 07:00:00 GMT
 concentra bids on atea, seeking to acquire another struggling biotech  BioPharma Dive Tue, 23 May 2023 07:00:00 GMT
 Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea  Fierce Biotech Mon, 22 May 2023 07:00:00 GMT
 concentra rebounds with a shot at covid-19-focused atea  Fierce Biotech Mon, 22 May 2023 07:00:00 GMT
 fierce biotech m&a tracker 2023: boehringer buys t3 ...  FierceBiotech Wed, 17 May 2023 10:06:33 GMT
 redx seeks further funding after revenues fall and losses widen  The Business Desk Wed, 17 May 2023 07:00:00 GMT
 sobi agrees to buy cti biopharma for $1.7bn  Pharmaceutical Technology Wed, 10 May 2023 07:00:00 GMT
 gilead acquires xinthera to bolster oncology and inflammation ...  MM+M Online Tue, 09 May 2023 07:00:00 GMT
 united therapeutics (uthr) q1 earnings beat, sales miss  TradingView Thu, 04 May 2023 07:00:00 GMT
 Jounce Therapeutics Announces Closing of Tender Offer  GlobeNewswire Wed, 03 May 2023 07:00:00 GMT
 long-term outcomes and molecular correlates of sotorasib ...  ASCO Journals Tue, 25 Apr 2023 07:00:00 GMT
 redx officially calls off jounce merger after concentra acquisition  MM+M Online Mon, 03 Apr 2023 07:00:00 GMT
 redx pharma formally calls time on jounce deal  Proactive Investors Australia Mon, 03 Apr 2023 07:00:00 GMT
 flare therapeutics further strengthens leadership team with key ...  PR Newswire Thu, 30 Mar 2023 07:00:00 GMT
 Jounce (JNCE) Up 21% on Accepting Concentra's Buyout Offer  Nasdaq Tue, 28 Mar 2023 07:00:00 GMT
 redx pharma 'disappointed' as jounce pulls out of merger  Proactive financial news Tue, 28 Mar 2023 07:00:00 GMT
 redx deal fails after rival backs out  The Times Tue, 28 Mar 2023 07:00:00 GMT
 Jounce Therapeutics Enters Into Agreement to Be Acquired by  GlobeNewswire Mon, 27 Mar 2023 07:00:00 GMT
 Jounce pivots, agrees to $96.5M acquisition by mysterious biotech  The Business Journals Mon, 27 Mar 2023 07:00:00 GMT

Jounce Therapeutics, Inc
(NASDAQ:JNCE) 

JNCE stock logo

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on...

Founded: 2012
Full Time Employees: 129
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends